| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Vattikuti Urology Institute, Henry Ford Health Sciences Center, Detroit, Michigan 48202
Resveratrol has an apoptotic effect on a variety of cancer cells. Changes in cell cycle regulatory processes contributing to the antiproliferative effect of resveratrol remain largely unknown. Our studies revealed that, in androgen-sensitive LNCaP cells, the effect of resveratrol on DNA synthesis varied dramatically depending on the concentration and the duration of treatment. In 1-h-treated cells, resveratrol showed only an inhibitory effect on DNA synthesis, which increased with increasing concentration (IC50 = 20 µM). However, when treatment duration was extended to 24 h, we observed a dual effect of resveratrol on DNA synthesis. At 5 to 10 µM it caused a 2- to 3-fold increase in DNA synthesis, and at
15 µM, it inhibited DNA synthesis. The increase in DNA synthesis was seen only in LNCaP cells, but not in androgen-independent DU145 prostate cancer cells or in NIH3T3 fibroblast cells. The resveratrol-induced increase in DNA synthesis was associated with enrichment of LNCaP cells in S phase, and a concurrent decrease in nuclear p21Cipl and p27Kip1 levels. Furthermore, consistent with the entry of LNCaP cells into S phase, there was a dramatic increase in nuclear Cdk2 activity associated with both cyclin A and cyclin E. Taken together, our observations indicate that LNCaP cells, treated with resveratrol, are induced to enter into S phase, but subsequent progression through S phase is limited by the inhibitory effect of resveratrol on DNA synthesis, particularly at concentrations above 15 µM. Therefore, this unique ability of resveratrol to exert opposing effects on two important processes in cell cycle progression, induction of S phase and inhibition of DNA synthesis, may be responsible for its apoptotic and antiproliferative effects.
This article has been cited by other articles:
![]() |
T. S. Hudson, D. K. Hartle, S. D. Hursting, N. P. Nunez, T. T.Y. Wang, H. A. Young, P. Arany, and J. E. Green Inhibition of Prostate Cancer Growth by Muscadine Grape Skin Extract and Resveratrol through Distinct Mechanisms Cancer Res., September 1, 2007; 67(17): 8396 - 8405. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. O. Kaseb, K. Chinnakannu, D. Chen, A. Sivanandam, S. Tejwani, M. Menon, Q. P. Dou, and G. P.-V. Reddy Androgen Receptor and E2F-1 Targeted Thymoquinone Therapy for Hormone-Refractory Prostate Cancer Cancer Res., August 15, 2007; 67(16): 7782 - 7788. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Ahmad, N. H. Harris, A. D. Johnson, H. C.N. Lindvall, G. Wang, and K. Ahmed Protein kinase CK2 modulates apoptosis induced by resveratrol and epigallocatechin-3-gallate in prostate cancer cells Mol. Cancer Ther., March 1, 2007; 6(3): 1006 - 1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-M. HO, Y.-K. LEUNG, and I. CHUNG Estrogens and Antiestrogens as Etiological Factors and Therapeutics for Prostate Cancer Ann. N.Y. Acad. Sci., November 1, 2006; 1089(1): 177 - 193. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kotha, M. Sekharam, L. Cilenti, K. Siddiquee, A. Khaled, A. S. Zervos, B. Carter, J. Turkson, and R. Jove Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein. Mol. Cancer Ther., March 1, 2006; 5(3): 621 - 629. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tyagi, R. P. Singh, C. Agarwal, S. Siriwardana, R. A. Sclafani, and R. Agarwal Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells Carcinogenesis, November 1, 2005; 26(11): 1978 - 1987. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jiang, L. Zhang, J. Kuo, K. Kuo, S. C. Gautam, L. Groc, A. I. Rodriguez, D. Koubi, T. Jackson Hunter, G. B. Corcoran, et al. Resveratrol-induced apoptotic death in human U251 glioma cells Mol. Cancer Ther., April 1, 2005; 4(4): 554 - 561. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Jones, S. E. DePrimo, M. L. Whitfield, and J. D. Brooks Resveratrol-Induced Gene Expression Profiles in Human Prostate Cancer Cells Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 596 - 604. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Shih, S. Zhang, H. J. Cao, S. Boswell, Y.-H. Wu, H.-Y. Tang, M. R. Lennartz, F. B. Davis, P. J. Davis, and H.-Y. Lin Inhibitory effect of epidermal growth factor on resveratrol-induced apoptosis in prostate cancer cells is mediated by protein kinase C-{alpha} Mol. Cancer Ther., November 1, 2004; 3(11): 1355 - 1364. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Mobley, J. O. L'Esperance, M. Wu, C. J. Friel, R. H. Hanson, and S.-M. Ho The novel estrogen 17{alpha}-20Z-21-[(4-amino)phenyl]-19-norpregna-1,3,5(10),20-tetraene-3,17{beta}-diol induces apoptosis in prostate cancer cell lines at nanomolar concentrations in vitro Mol. Cancer Ther., May 1, 2004; 3(5): 587 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-H. Tseng, S.-M. Lin, J.-C. Chen, Y.-H. Su, H.-Y. Huang, C.-K. Chen, P.-Y. Lin, and Y. Chen Resveratrol Suppresses the Angiogenesis and Tumor Growth of Gliomas in Rats Clin. Cancer Res., March 15, 2004; 10(6): 2190 - 2202. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Opipari Jr., L. Tan, A. E. Boitano, D. R. Sorenson, A. Aurora, and J. R. Liu Resveratrol-induced Autophagocytosis in Ovarian Cancer Cells Cancer Res., January 15, 2004; 64(2): 696 - 703. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Filomeni, K. Aquilano, G. Rotilio, and M. R. Ciriolo Reactive Oxygen Species-dependent c-Jun NH2-terminal Kinase/c-Jun Signaling Cascade Mediates Neuroblastoma Cell Death Induced by Diallyl Disulfide Cancer Res., September 15, 2003; 63(18): 5940 - 5949. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Deeb, Y. X. Xu, H. Jiang, X. Gao, N. Janakiraman, R. A. Chapman, and S. C. Gautam Curcumin (Diferuloyl-Methane) Enhances Tumor Necrosis Factor-related Apoptosis-inducing Ligand-induced Apoptosis in LNCaP Prostate Cancer Cells Mol. Cancer Ther., January 1, 2003; 2(1): 95 - 103. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Banerjee, C. Bueso-Ramos, and B. B. Aggarwal Suppression of 7,12-Dimethylbenz(a)anthracene-induced Mammary Carcinogenesis in Rats by Resveratrol: Role of Nuclear Factor-{kappa}B, Cyclooxygenase 2, and Matrix Metalloprotease 9 Cancer Res., September 1, 2002; 62(17): 4945 - 4954. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |